These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35349635)

  • 21. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain.
    Ramos-Rincon JM; Pinargote-Celorio H; de Mendoza C; Ramos-Belinchón C; Barreiro P; Treviño A; Corral O; Soriano V
    Aliment Pharmacol Ther; 2023 Mar; 57(5):540-548. PubMed ID: 36320189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort.
    Maponga TG; McNaughton AL; van Schalkwyk M; Hugo S; Nwankwo C; Taljaard J; Mokaya J; Smith DA; van Vuuren C; Goedhals D; Gabriel S; Andersson MI; Preiser W; van Rensburg C; Matthews PC
    J Infect; 2020 Jul; 81(1):121-130. PubMed ID: 32360882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of serum hepatitis B core-related antigen with hepatitis B virus total intrahepatic DNA and covalently closed circular-DNA viral load in HIV-hepatitis B coinfection.
    Dezanet LNC; Maylin S; Gabassi A; Rougier H; Miailhes P; Lascoux-Combe C; Chas J; Girard PM; Delaugerre C; Zoulim F; Lacombe K; Boyd A
    AIDS; 2020 Nov; 34(13):1943-1949. PubMed ID: 32773480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment.
    Singh KP; Crane M; Audsley J; Avihingsanon A; Sasadeusz J; Lewin SR
    AIDS; 2017 Sep; 31(15):2035-2052. PubMed ID: 28692539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.
    Ive P; MacLeod W; Mkumla N; Orrell C; Jentsch U; Wallis CL; Stevens W; Wood R; Sanne I; Bhattacharya D
    PLoS One; 2013; 8(12):e74900. PubMed ID: 24324573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies.
    Kamal H; Fornes R; Simin J; Stål P; Duberg AS; Brusselaers N; Aleman S
    J Viral Hepat; 2021 Oct; 28(10):1431-1442. PubMed ID: 34291520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of Chronic Hepatitis B in HIV-Coinfected Patients.
    Fasano M; Poliseno MC; Fiore JR; Lo Caputo S; D'Arminio Monforte A; Santantonio TA
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection.
    Khalili M; King WC; Kleiner DE; Jain MK; Chung RT; Sulkowski M; Lisker-Melman M; Wong DK; Ghany M; Sanyal A; Sterling RK
    Clin Infect Dis; 2021 Nov; 73(9):e3275-e3285. PubMed ID: 32869840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.
    Sun HY; Sheng WH; Tsai MS; Lee KY; Chang SY; Hung CC
    World J Gastroenterol; 2014 Oct; 20(40):14598-614. PubMed ID: 25356024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
    Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
    JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
    Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
    BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent hepatitis B virus and HIV coinfections in dually humanized mice engrafted with human liver and immune system.
    Hogan G; Winer BY; Ahodantin J; Sellau J; Huang T; Douam F; Funaki M; Chiriboga L; Su L; Ploss A
    J Med Virol; 2023 Jul; 95(7):e28930. PubMed ID: 37403703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
    Alfaiate D; Clément S; Gomes D; Goossens N; Negro F
    J Hepatol; 2020 Sep; 73(3):533-539. PubMed ID: 32151618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204.
    Hwang JP; Arnold KB; Unger JM; Chugh R; Tincopa MA; Loomba R; Hershman D; Ramsey SD
    Support Care Cancer; 2022 Dec; 31(1):93. PubMed ID: 36585488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.
    Lieveld FI; Smit C; Richter C; van Erpecum KJ; Spanier BWM; Gisolf EH; Vrolijk JM; Siersema PD; Hoepelman AIM; Reiss P; Arends JE
    Liver Int; 2019 Mar; 39(3):470-483. PubMed ID: 30411848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review article: the prevention of hepatitis B-related hepatocellular carcinoma.
    Lin CL; Kao JH
    Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.
    Maponga TG; Glashoff RH; Vermeulen H; Robertson B; Burmeister S; Bernon M; Omoshoro-Jones J; Ruff P; Neugut AI; Jacobson JS; Preiser W; Andersson MI
    BMC Gastroenterol; 2020 Jul; 20(1):226. PubMed ID: 32660431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: more aggressive tumor behavior?
    Saud LRC; Chagas AL; Maccali C; Pinto PVA; Horvat N; Alencar RSSM; Tani CM; Abdala E; Carrilho FJ
    Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):583-588. PubMed ID: 33560682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.
    Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL
    Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.